215 related articles for article (PubMed ID: 8524630)
1. [Allogeneic bone marrow transplantation in malignant blood diseases].
Ruutu T
Nord Med; 1995; 110(12):310-3. PubMed ID: 8524630
[TBL] [Abstract][Full Text] [Related]
2. [Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases].
Gratwohl A
Ther Umsch; 1996 Feb; 53(2):152-7. PubMed ID: 8629266
[TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
4. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma.
Nakase K; Hara M; Kozuka T; Tanimoto K; Nawa Y
Bone Marrow Transplant; 2006 Jan; 37(1):41-4. PubMed ID: 16247419
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
7. Haematopoietic stem cell transplantation: current status.
Kumar L
Natl Med J India; 2007; 20(3):128-37. PubMed ID: 17867617
[TBL] [Abstract][Full Text] [Related]
8. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
[TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
11. [Patient information and conditioning for allogeneic stem cell transplantation].
Brinch L
Nord Med; 1995; 110(12):318-9, 322. PubMed ID: 8524634
[TBL] [Abstract][Full Text] [Related]
12. [Donor selection for allogenic bone marrow transplantation from 1991 to 1995. (The Prague Center for Bone Marrow Transplantation)].
Korínková P; Matĕjková E; Vítek A
Cas Lek Cesk; 1996 Jun; 135(12):389-92. PubMed ID: 8706078
[TBL] [Abstract][Full Text] [Related]
13. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation.
Bosi A; Bartolozzi B; Guidi S
Transplant Proc; 2005; 37(6):2667-9. PubMed ID: 16182779
[TBL] [Abstract][Full Text] [Related]
17. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
Cesaro S; Pillon M; Visintin G; Putti MC; Gazzola MV; D'Amore E; Scarzello G; Zanesco L; Messina C; Rosolen A
Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]